Skip to search formSkip to main contentSkip to account menu

Glatiramer

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objective To determine the effect of vitamin D3 on interferon-β (IFN-β) response and immune regulation in MS mononuclear cells… 
Review
2013
Review
2013
Multiple sclerosis will usually calm down during pregnancy, but the number of relapses again increases immediately after… 
2012
2012
Two manufacturer sponsored phase III trials suggest that alemtuzumab, an anti-CD52 monoclonal antibody that is licensed to treat… 
Review
2009
Review
2009
Purpose of review This update includes topics relating to the treatment of multiple sclerosis (MS) for the ophthalmologist… 
2006
2006
Pivotal trials have demonstrated partial, short-term benefit from treatment with immunomodulatory agents in patients with either… 
2005
2005
Many women with multiple sclerosis (MS) ask about the risks of pregnancy before starting (or while on) disease-modifying… 
2005
2005
The present invention relates to processes for preparing a polypeptide or pharmaceutically acceptable salt thereof comprising L… 
2005
2005
Un proceso para la preparacion de un polipeptido que contiene L-tirosina, L-alanina, L-glutamina y L-lisina, o una sal… 
2003
2003
EDITOR—We agree with Sudlow and Counsell that the evidence for the risk sharing scheme for interferon beta and glatiramer in…